Ignite Creation Date:
2024-05-06 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06229366
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-01-03
Brief Title:
Ac-225-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
Sponsor:
POINT Biopharma a wholly owned subsidiary of Eli Lilly and Company
Organization:
POINT Biopharma a wholly owned subsidiary of Eli Lilly and Company
Organization Data
Organization:
POINT Biopharma a wholly owned subsidiary of Eli Lilly and Company
Class:
INDUSTRY
Study ID:
PSMA-62-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
POINT Biopharma a wholly owned subsidiary of Eli Lilly and Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |